Loading patent…
AssigneeNovovasc LLC
InventorsGerald M. Rosen, William R. Herzog, Jr., Sovitj Pou
Estimating the term…
A surface of a foreign body exposed to the flowing blood of a living being which normally would promote the aggregation of platelets in that blood to form a layer affixed to that surface and thus restrict the flow of blood past that surface or to form a blood clot detachable from that surface which when detached could trigger a stroke, heart attack or partial loss of organ function, such as plastic tubing, a balloon or the end of a catheter surgically inserted in a blood vessel or a stent implanted therein, e.g., in conjunction with percutaneous transluminal coronary angioplasty or the interior wall of a length of plastic tubing used to transport the blood of a patient, undergoing hypothermic surgery or dialysis, inhibits such aggregation when that surface is coated with a physiologically acceptable polymer, such as polyvinyl alcohol or polyvinyl chloride, containing dissolved or dispersed therein a nitrosyl-containing organometallic compound, whether ionic salt or chelate, which slowly decomposes at the body temperature and in so doing releases a platelet aggregation-inhibiting amount of nitric oxide during either the post-surgical period when the individual is a high risk candidate for post-surgical foreign body-mediated platelet aggregation on or at the situs of the foreign body or during dialysis of the blood to remove waste in those individuals with dysfunctional kidneys.
In a method for producing a medical device capable of inhibiting the aggregation of platelets from blood flowing in a living being resulting from exposure of the blood to a medical device by coating the surface of the foreign body prior to contact therewith, with a physiologically acceptable polymer coating which contains dissolved or dispersed therein a therapeutic drug, the improvement wherein the polymer coating is insoluble in the blood and has a porosity sufficiently small to inhibit diffusion of blood-borne reductants from entering the coating and sufficiently large to allow passive diffusion of nitric oxide from within the polymer coating into the blood stream of the living being and contains dissolved or dispersed therein as the therapeutic drug and the source of the nitric oxide an amount of a nitrosyl-containing organometallic compound, which slowly decomposes at body temperature within the polymer coating when the device is exposed to the blood stream of the living being and in so doing releases from the coating into the blood stream an amount of nitric oxide effective to inhibit platelet aggregation which would otherwise be promoted by contact of the blood with the foreign body.
In a device adapted for exposure to blood flowing in a living being, said device having an exterior surface coated with a coating of a physiologically acceptable polymer which contains dissolved or dispersed therein a therapeutic drug, the improvement wherein the polymer coating is insoluble in the blood and has a porosity sufficiently small to inhibit diffusion of blood-borne reductants from entering the coating and sufficiently large to allow passive diffusion of nitric oxide from within the polymer coating into the blood stream of the living being and contains dissolved or dispersed therein as therapeutic drug and the source of the nitric oxide an amount of a nitrosyl-containing organometallic compound which slowly at the body temperature of the living being decomposes within the polymer coating when the device is exposed to the blood of the blood stream of the living being and in so doing releases from the coating into the blood stream an amount of nitric oxide at a rate effective to mediate the platelet aggregation which could otherwise occur after the device is exposed to the blood.
Dependencies are inferred from the claim text.